Cellectis S.A. ADR (NQ: CLLS )
2.370
+0.050
(+2.16%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Cellectis S.A. ADR
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](/next-assets/images/schema-image-default.png)
Recap: Cellectis Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Cellectis
April 05, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
From Cellectis Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
A Preview Of Cellectis's Earnings
March 07, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_150.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://www.marketbeat.com/logos/articles/small_20230221075622_theres-a-lot-of-upside-for-emerging-gene-editing-c.jpg)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Friday's Intraday Session
February 03, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 03, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
Cellectis Announces Pricing of Follow-On Offering
February 03, 2023
From Cellectis Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Thursday's After-Market Session
February 02, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
Cellectis Announces Launch of Follow-On Offering
February 02, 2023
From Cellectis Inc.
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
![](https://investorplace.com/wp-content/uploads/2019/09/deal-handshake.jpg)
![](https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png)
From Cellectis Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.